IN2014DN06805A - - Google Patents

Info

Publication number
IN2014DN06805A
IN2014DN06805A IN6805DEN2014A IN2014DN06805A IN 2014DN06805 A IN2014DN06805 A IN 2014DN06805A IN 6805DEN2014 A IN6805DEN2014 A IN 6805DEN2014A IN 2014DN06805 A IN2014DN06805 A IN 2014DN06805A
Authority
IN
India
Prior art keywords
synthon
composition
imaging
labelled
improved
Prior art date
Application number
Other languages
English (en)
Inventor
Rajiv Bhalla
Alexander Jackson
Gareth Smith
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of IN2014DN06805A publication Critical patent/IN2014DN06805A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN6805DEN2014 2012-03-30 2013-03-28 IN2014DN06805A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261617698P 2012-03-30 2012-03-30
GBGB1205703.0A GB201205703D0 (en) 2012-03-30 2012-03-30 Synthon composition
PCT/EP2013/056720 WO2013144301A2 (fr) 2012-03-30 2013-03-28 Composition de synthon

Publications (1)

Publication Number Publication Date
IN2014DN06805A true IN2014DN06805A (fr) 2015-06-26

Family

ID=46160043

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6805DEN2014 IN2014DN06805A (fr) 2012-03-30 2013-03-28

Country Status (10)

Country Link
US (1) US20160022845A1 (fr)
EP (1) EP2830667A2 (fr)
JP (1) JP2015511620A (fr)
KR (1) KR20140141604A (fr)
CN (1) CN104168924A (fr)
AU (1) AU2013241713A1 (fr)
CA (1) CA2866226A1 (fr)
GB (1) GB201205703D0 (fr)
IN (1) IN2014DN06805A (fr)
WO (1) WO2013144301A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161478A (en) 1974-05-02 1979-07-17 General Electric Company Photoinitiators
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
US8257680B1 (en) * 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
EP2110367A1 (fr) * 2008-04-14 2009-10-21 Bayer Schering Pharma Aktiengesellschaft Stratégie de purification pour procédures nucléophiliques directes
CA2748691A1 (fr) 2008-12-12 2010-06-17 Lutz Lehmann Composes de triaryl-sulphonium, kit et procede pour etiqueter des isotopes emettant des positrons
WO2011141515A1 (fr) * 2010-05-14 2011-11-17 Bayer Pharma Aktiengesellschaft Agents de diagnostic pour l'imagerie d'amyloïdes bêta

Also Published As

Publication number Publication date
JP2015511620A (ja) 2015-04-20
WO2013144301A2 (fr) 2013-10-03
EP2830667A2 (fr) 2015-02-04
GB201205703D0 (en) 2012-05-16
CA2866226A1 (fr) 2013-10-03
WO2013144301A3 (fr) 2013-11-21
AU2013241713A1 (en) 2014-10-02
US20160022845A1 (en) 2016-01-28
CN104168924A (zh) 2014-11-26
KR20140141604A (ko) 2014-12-10

Similar Documents

Publication Publication Date Title
MX2013012793A (es) Aminoacidos radiomarcados para imagen de diagnostico.
MX353254B (es) Radioligandos marcados con fluor-18 y carbono-11 para la formacion de imagenes por tomografia de emision de positrones para proteina cinasa 2 de repeticion rica en leucina (lrrk2).
IN2015KN00262A (fr)
ECSP12011787A (es) Polipéptidos para unión al "receptor para productos finales de glicosilación avanzada" así como composiciones y métodos que implican a los mismos
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
UY32037A (es) Daa-piridina
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
NZ606466A (en) Peptide radiotracer compositions
MX2013010012A (es) Analogos de octreotato radiomarcado como trazadores de tomografia por emision de positrones.
WO2015153772A3 (fr) Complexe zirconium 89-oxine utilisé en tant qu'agent de marquage de cellule pour tomographie par émission de positrons
MX2011010295A (es) Reactivos de radiomarcado y metodos.
MX342171B (es) Peptido o complejo peptidico que se une a integrina ?2 y metodos y usos que implican a los mismos.
UA110128C2 (uk) Індолкарбоксаміди та бензімідазолкарбоксаміди як інсектициди та акарициди
GB201103696D0 (en) Technetium labelled peptides
IN2014DN06805A (fr)
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
IN2015DN00085A (fr)
MX340487B (es) Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.
MX2013006202A (es) Metodo de radioconjugacion.
MX355719B (es) Composicion farmaceutica en forma de una suspension oral que comprende una fraccion flavonoica y goma de xantano.
MX340407B (es) Simplificacion de proceso para compuesto precursor.
MX368061B (es) Proceso de radioetiquetado.
WO2012040133A3 (fr) Nouveau précuseur
MX2013010781A (es) Compuestos para usarse en formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.